Serum-Werk Bernburg

Serum-Werk Bernburg is a medium-sized German pharmaceutical company specializing in the development and production of human and veterinary medicines, as well as medical devices. Founded in 1954, the company has established itself as a global leader in the production of iron dextran complexes used for treating iron deficiency. Their portfolio includes a wide range of infusion and injection solutions, hydroxyethyl starch (HES) for volume replacement, and specialized wound care products. Additionally, the company provides extensive contract manufacturing services (CDMO) for international partners, leveraging its GMP-certified facilities. Serum-Werk Bernburg also maintains a significant presence in the veterinary market with vaccines and pharmaceuticals for livestock.